Business Context and Reporting Period
Company: AeroVironment, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 20, 2025
Event: Amendment and restatement of the Company's bylaws (Sixth Amended and Restated Bylaws), effective immediately.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a corporate governance report regarding bylaw amendments.
Material Changes
The Board of Directors approved substantive amendments to the Company's bylaws on November 20, 2025. Key changes include:
- Implementation of a right to cure process for deficiencies in stockholder director nomination notices.
- Authority for the Board to postpone, reschedule, or cancel annual stockholder meetings.
- Authority for the Chairman, CEO, or Board to postpone, reschedule, or cancel special stockholder meetings.
- Revisions to advance notice provisions for director nominations and other business proposals to align with Delaware law.
- Provision allowing directors to hold special meetings on less than 48 hours' notice if necessary.
- Inclusion of a severability provision.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on operations, or specific risk factors beyond the governance changes described. The amendments are intended to align the Company's procedures with current legal developments and best practices.
Key Facts for Investor Verification
- Verify the full text of the Sixth Amended and Restated Bylaws attached as Exhibit 3.1 to this filing.
- Confirm the specific procedural requirements for stockholder nominations under the new "right to cure" process.
- Review the updated notice periods for special meetings and director nominations.